ArticleFrontiers in microbiology2026
Detection of ongoing asymptomatic
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Asymptomatic hosts can shed pathogens without showing clinical symptoms, making them invisible to routine screenings and potent drivers of pathogen dissemination and epidemic outbreaks. The lack of reliable, cost-effective tools for large-scale identification of asymptomatic infections hampers early intervention and control strategies. Methods: We improved the IgG serodynamics-based epitope discovery method by integrating clustering and high-level analysis, which helped us identify linear epitopes with immunogenicity from a large number of candidate epitopes. Epitopes were filtered using negative sera identified by virus neutralization tests (VNT) to eliminate highly antigenic probes. These remaining low antigenicity probes were used to construct a protein-peptide hybrid microarray (PPHM Results: The PPHM Conclusion: The study provides a novel, specific, and practical platform for detecting asymptomatic PDCoV infections based on serological TPI signatures. It offers early warning and disease prevention strategies in livestock and establishes a framework for future monitoring of potential interspecies transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.